
Bristol-Myers Squibb
North America, New York, United States, New York
Description
Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Investor Profile
Bristol-Myers Squibb has made 100 investments, with 16 in the past 12 months and 32% as lead.
Stage Focus
- Series B (31%)
- Series A (21%)
- Grant (16%)
- Series C (14%)
- Post Ipo Equity (6%)
- Series Unknown (4%)
- Series D (3%)
- Corporate Round (3%)
- Series G (1%)
- Debt Financing (1%)
Country Focus
- United States (73%)
- United Kingdom (10%)
- Germany (3%)
- France (3%)
- Denmark (2%)
- India (2%)
- Brazil (2%)
- Israel (2%)
- Spain (1%)
- Switzerland (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Health Diagnostics
- Oncology
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.